Patients with Crohn's Disease and Ileostomy Can Respond to Upadacitinib. Loeb L, Farraye FA, Crosby S, Loftus EV Jr, et al. Dig Dis Sci 2025 Jun 14. doi: 10.1007/s10620-025-09125.

Read + Share

Amedeo Smart

Independent Medical Education

Loeb L, Farraye FA, Crosby S, Loftus EV Jr, et al. Patients with Crohn's Disease and Ileostomy Can Respond to Upadacitinib. Dig Dis Sci 2025 Jun 14. doi: 10.1007/s10620-025-09125.
PMID: 40515784